APA (7th ed.) Citation

Foster, T. P., Jacobsen, L. M., Bruggeman, B., Salmon, C., Hosford, J., Chen, A., . . . Haller, M. J. (2024). Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes. Diabetes care, 47(2), 285-289. https://doi.org/10.2337/dc23-1750

Chicago Style (17th ed.) Citation

Foster, Timothy P., et al. "Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes." Diabetes Care 47, no. 2 (2024): 285-289. https://doi.org/10.2337/dc23-1750.

MLA (9th ed.) Citation

Foster, Timothy P., et al. "Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes." Diabetes Care, vol. 47, no. 2, 2024, pp. 285-289, https://doi.org/10.2337/dc23-1750.